Global Galectin Inhibitor Therapeutics Market Report By Indication (Fibrosis,Cancer immunotherapy,Dermatology,Others), By Route of Aministration (Oral,Parenteral,Others), By End-Users (Hospitals,Homecare,Specialty Clinics,Others), By Distribution Channel (hospital pharmacy,online pharmacy,retail pharmacy) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11213815
November 2020
Report Formats:

The global demand for Galectin Inhibitor Therapeutics Market is presumed to reach the valuation of nearly USD XXX MN by 2027 from USD XXX MN in 2020 with a CAGR of X.XX% under the study period of 2020 - 2027. 

Galectin inhibitor therapeutics are potential drugs used in treating inflammatory disorders and in cancer immunotherapy. Galectin inhibitors enhance the immune system function to fight against cancer cells, increase the tumor-infiltrating lymphocytes, reduce lung metastases, and reduce tumor vasculature. Galectins are a subfamily of lectin proteins present in human tissue and blood. They act as a biomarker for several chronic diseases such as cardiac insufficiency, diabetes, rheumatoid arthritis, asthma, chronic inflammatory severe skin diseases, including plaque psoriasis and atopic dermatitis, and liver cirrhosis. Extensively used in oncology treatment, galectin inhibitors, along with chemotherapy and radiotherapy, improves the efficacy of treatment of various neoplasms.

Market Dynamics

The great potential of galectin inhibitor therapeutics in cancer treatment, fibrosis, and cardiovascular diseases is the primary stimulant anticipated to drive this market’s growth. The attractive therapeutic opportunity offered by these anti-migratory, anti-invasive, and anti-angiogenic galectin inhibitors in treating several chronic diseases will further propel market growth. The emergence of galectin protein as a significant focus of research and pharmaceutical development for a wide range of medical conditions will boost the market growth. This market’s critical challenges are the complexities of developing effective therapeutics and the delivery of intact galectin to the desired site.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each segment in the global market of galectin inhibitor therapeutics.

Market Segmentation

This section of the galectin inhibitor therapeutics market report  provides detailed data on the segments by analyzing them grographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.

By Indication 

  • Fibrosis
  • Cancer immunotherapy
  • Dermatology
  • Others

By Route of Aministration
  • Oral
  • Parenteral
  • Others

By End-Users
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Distribution Channel
  • hospital pharmacy
  • online pharmacy
  • retail pharmacy

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for Galectin Inhibitor Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Europe Galectin Inhibitor Therapeutics Market by Revenue (USD MN)



The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the galectin inhibitor therapeutics market include Galectin Therapeutics Inc, MandalMed, Inc, G3 Pharmaceuticals, Angion, iTeos, GlycoMimetics, and Galecto Biotech among others.S. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
METHODOLOGY:

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications. 

If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . GALECTIN INHIBITOR THERAPEUTICS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Indication
           3.7.2 By Route of Aministration
           3.7.3 By End Users
           3.7.4 By Distribution Channel
           3.7.5 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL GALECTIN INHIBITOR THERAPEUTICS MARKET ANALYSIS BY INDICATION
       6.1 Overview by Indication
       6.2 Historical and Forecast Data
       6.3 Analysis by Indication
       6.4 Fibrosis Market by Regions
       6.6 Cancer immunotherapy Market by Regions
       6.5 Dermatology Market by Regions
       6.7 Others Market by Regions
 
7 . GLOBAL GALECTIN INHIBITOR THERAPEUTICS MARKET ANALYSIS BY ROUTE OF AMINISTRATION
       7.1 Overview by Route of Aministration
       7.2 Historical and Forecast Data
       7.3 Analysis by Route of Aministration
       7.4 Oral Market by Regions
       7.5 Parenteral Market by Regions
       7.6 Others Market by Regions
 
8 . GLOBAL GALECTIN INHIBITOR THERAPEUTICS MARKET ANALYSIS BY END USERS
       8.1 Overview by End Users
       8.2 Historical and Forecast Data
       8.3 Analysis by End Users
       8.4 Hospitals Market by Regions
       8.5 Homecare Market by Regions
       8.6 Specialty Clinics Market by Regions
       8.7 Others Market by Regions
 
9 . GLOBAL GALECTIN INHIBITOR THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       9.1 Overview by Distribution Channel
       9.2 Historical and Forecast Data
       9.3 Analysis by Distribution Channel
       9.4 Hospital Pharmacy Market by Regions
       9.5 Online Pharmacy Market by Regions
       9.6 Retail Pharmacy Market by Regions
 
10 . GLOBAL GALECTIN INHIBITOR THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
       10.1. Regional Outlook
       10.2. Introduction
       10.3. North America
           10.3.1. Overview, Historic and Forecast Data
           10.3.2. North America By Segment
           10.3.3. North America By Country
           10.3.4. United State
           10.3.5. Canada
           10.3.6. Mexico
       10.4. Europe
           10.4.1. Overview, Historic and Forecast Data
           10.4.2. Europe by Segment
           10.4.3. Europe by Country
           10.4.4. United Kingdom
           10.4.5. France
           10.4.6. Germany
           10.4.7. Italy
           10.4.8. Russia
           10.4.9. Rest Of Europe
       10.5. Asia Pacific
           10.5.1. Overview, Historic and Forecast Data
           10.5.2. Asia Pacific by Segment
           10.5.3. Asia Pacific by Country
           10.5.4. China
           10.5.5. India
           10.5.6. Japan
           10.5.7. South Korea
           10.5.8. Australia
           10.5.9. Rest Of Asia Pacific
       10.6. Latin America
           10.6.1. Overview, Historic and Forecast Data
           10.6.2. Latin America by Segment
           10.6.3. Latin America by Country
           10.6.4. Brazil
           10.6.5. Argentina
           10.6.6. Peru
           10.6.7. Chile
           10.6.8. Rest of Latin America
       10.7. Middle East & Africa
           10.7.1. Overview, Historic and Forecast Data
           10.7.2. Middle East & Africa by Segment
           10.7.3. Middle East & Africa by Country
           10.7.4. Saudi Arabia
           10.7.5. UAE
           10.7.6. Israel
           10.7.7. South Africa
           10.7.8. Rest Of Middle East And Africa
 
11 . COMPETITIVE LANDSCAPE OF THE GALECTIN INHIBITOR THERAPEUTICS COMPANIES
       11.1. Galectin Inhibitor Therapeutics Market Competition
       11.2. Partnership/Collaboration/Agreement
       11.3. Merger And Acquisitions
       11.4. New Product Launch
       11.5. Other Developments
 
12 . COMPANY PROFILES OF GALECTIN INHIBITOR THERAPEUTICS INDUSTRY
       12.1. Company Share Analysis
       12.2. Market Concentration Rate
       12.3. Galectin Therapeutics Inc.
           12.3.1. Company Overview
           12.3.2. Financials
           12.3.3. Products
           12.3.4. Recent Developments
       12.4. MandalMed Inc.
           12.4.1. Company Overview
           12.4.2. Financials
           12.4.3. Products
           12.4.4. Recent Developments
       12.5. G3 Pharmaceuticals
           12.5.1. Company Overview
           12.5.2. Financials
           12.5.3. Products
           12.5.4. Recent Developments
       12.6. Angion
           12.6.1. Company Overview
           12.6.2. Financials
           12.6.3. Products
           12.6.4. Recent Developments
       12.7. iTeos
           12.7.1. Company Overview
           12.7.2. Financials
           12.7.3. Products
           12.7.4. Recent Developments
       12.8. GlycoMimetics
           12.8.1. Company Overview
           12.8.2. Financials
           12.8.3. Products
           12.8.4. Recent Developments
       12.9. Galecto Biotech
           12.9.1. Company Overview
           12.9.2. Financials
           12.9.3. Products
           12.9.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Indication  (USD MN)
  • Fibrosis Market by Geography (USD MN)
  • Cancer immunotherapy Market by Geography (USD MN)
  • Dermatology Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis Market by Route of Aministration (USD MN)
  • Oral Market by Geography (USD MN)
  • Parenteral Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by End Users (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Homecare Market by Geography (USD MN)
  • Specialty Clinics Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacy Market by Geography (USD MN)
  • Online Pharmacy Market by Geography (USD MN)
  • Retail Pharmacy Market by Geography (USD MN)
  • Global Galectin Inhibitor Therapeutics Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Galectin Inhibitor Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Galectin Inhibitor Therapeutics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Route of Aministration
  • Market Attractiveness Analysis by End Users
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Segment Analysis 1 (USD MN)
  • Fibrosis Market by Geography (USD MN)
  • Cancer immunotherapy Market by Geography (USD MN)
  • Dermatology Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Route of Aministration (USD MN)
  • Oral Market by Geography (USD MN)
  • Parenteral Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by End Users (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Homecare Market by Geography (USD MN)
  • Specialty Clinics Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacy Market by Geography (USD MN)
  • Online Pharmacy Market by Geography (USD MN)
  • Retail Pharmacy Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials